| Followers | 177 |
| Posts | 11263 |
| Boards Moderated | 0 |
| Alias Born | 04/04/2011 |
Monday, December 19, 2011 3:58:31 PM
Nobody by no means is asking anyone to take a loss by selling here! Does anyone think they are helping the pps by perceiving everything is false because they do not see proof that meets their approval and then berates the CEO and the company by calling it a scam because a deal hasn't been made to date.
I mean come on, this is an issue that does need addressing and when a few of us tried approaching it in a logical manner to get answers, few were willing to go that route. Does anyone think that a message board is the correct format to address issues with a CEO? Does anyone think that threats and made up allegations about the company is going to resolve anything?
Sure we all want answers, but if those answers do not come within the time some want, then should it mean that the company is stalling or hiding something? Like I said and others agree that this is how it is here in pinkyland!
BTW - Did you ever consider that folks associated with the racetrack could have made statements that they shouldn't have and led Mr. Swank to believe that in fact that the letter of acceptance meant it was just a matter of time before the final formalities were put in place to ok the lease deal to Mr. Swank? It could just possibly been a very bad miss-communication, where one person thought this while another thought that.
I agree that this is a big learning curve for Mr. Swank, just as the fights were and mistakes were made and recently admitted to. Is this what we wanted? Heck no, but it is what it is and it needs to be dealt with the best way possible and just because he doesn't do it the way you suggest, doesn't make it completely wrong.
There always two sides to every coin and in time we will get to the bottom of it and hopefully things can be salvaged here very soon.If one thinks differently, then one has to make a decision based on their investing strategy and what they choose to believe. It's not that complicated imo.
Cheers!
I mean come on, this is an issue that does need addressing and when a few of us tried approaching it in a logical manner to get answers, few were willing to go that route. Does anyone think that a message board is the correct format to address issues with a CEO? Does anyone think that threats and made up allegations about the company is going to resolve anything?
Sure we all want answers, but if those answers do not come within the time some want, then should it mean that the company is stalling or hiding something? Like I said and others agree that this is how it is here in pinkyland!
BTW - Did you ever consider that folks associated with the racetrack could have made statements that they shouldn't have and led Mr. Swank to believe that in fact that the letter of acceptance meant it was just a matter of time before the final formalities were put in place to ok the lease deal to Mr. Swank? It could just possibly been a very bad miss-communication, where one person thought this while another thought that.
I agree that this is a big learning curve for Mr. Swank, just as the fights were and mistakes were made and recently admitted to. Is this what we wanted? Heck no, but it is what it is and it needs to be dealt with the best way possible and just because he doesn't do it the way you suggest, doesn't make it completely wrong.
There always two sides to every coin and in time we will get to the bottom of it and hopefully things can be salvaged here very soon.If one thinks differently, then one has to make a decision based on their investing strategy and what they choose to believe. It's not that complicated imo.
Cheers!
Recent BSEM News
- BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026 • GlobeNewswire Inc. • 04/08/2026 11:00:00 AM
- BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/31/2026 08:05:00 PM
- BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025 • GlobeNewswire Inc. • 03/30/2026 11:00:00 AM
- BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/24/2026 08:05:00 PM
- BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair • GlobeNewswire Inc. • 03/23/2026 03:40:56 PM
- BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026 • GlobeNewswire Inc. • 03/11/2026 08:05:00 PM
- BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference • GlobeNewswire Inc. • 02/20/2026 12:00:00 PM
- BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research • GlobeNewswire Inc. • 02/03/2026 09:05:00 PM
- BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business • GlobeNewswire Inc. • 01/21/2026 10:30:00 PM
- BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes • GlobeNewswire Inc. • 01/07/2026 09:05:00 PM
- BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes • GlobeNewswire Inc. • 12/18/2025 12:00:00 PM
- BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference • GlobeNewswire Inc. • 12/10/2025 12:00:00 PM
- BioStem Technologies Expands Product Access in Medicaid • GlobeNewswire Inc. • 11/25/2025 01:59:13 PM
- BioStem Technologies Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/13/2025 09:02:00 PM
- BioStem Technologies Announces Filing of Restated Financial Statements • GlobeNewswire Inc. • 11/13/2025 09:01:00 PM
- BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes • GlobeNewswire Inc. • 11/05/2025 09:05:00 PM
- BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters • GlobeNewswire Inc. • 11/05/2025 12:00:00 PM
- BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers • GlobeNewswire Inc. • 10/31/2025 11:00:00 AM
- BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025 • GlobeNewswire Inc. • 10/30/2025 08:05:00 PM
- BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant • GlobeNewswire Inc. • 10/27/2025 08:15:00 PM
- BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program • GlobeNewswire Inc. • 10/02/2025 04:00:00 PM
